Fig. 5.
Ad5 NAb titers over time in six mCRC patients immunized with Ad5 [E1-, E2b-]-CEA(6D). Titers increased in all patients by week 9 (3 weeks after the last immunization) and then decreased thereafter
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.